Drug metabolites are created when a drug is metabolized into a different form that still has therapeutic effects. Active metabolites can be produced by drug metabolism redox reactions like heteroatom dealkylations, hydroxylations, heteroatom oxygenations, reductions, and dehydrogenations. In some rare circumstances, conjugation reactions can also produce an active metabolite.
Structure | Cat No. | Product Name | CAS No. | Product Description |
---|---|---|---|---|
V38232 | Mebeverine acid | 475203-77-1 | Mebeverine acid (Mebeverine metabolite Mebeverine acid) is a secondary metabolite (SM, chemical compound) of Mebeverine. | |
V34673 | Mebeverine alcohol (Mebeverine metabolite) | 14367-47-6 | Mebeverine alcohol is a major metabolite of Mebeverine which is a musculotropic antispasmodic drug. | |
V32648 | meta-Fexofenadine (meta-MDL-16455 | 479035-75-1 | meta-Fexofenadine (meta-MDL-1645; meta-MDL16455) is an impurity of Fexofenadine (Allegra;MDL-16455A; MDL16455A; Telfast), which is a histamine H1 receptor antagonist (antihistamine) approved for the treatment of allergy including hay fever, nasal congestion, and urticaria. | |
V21871 | Molsidomine | 25717-80-0 | Molsidomine is anorally bioactive and long acting vasodilator acting as anNO donor and annexin A2 inhibitor. | |
V72215 | Mono(5-carboxy-2-ethylpentyl) phthalate (MECPP) | 40809-41-4 | Mono(5-carboxy-2-ethylpentyl) phthalate (MECPP) is a metabolite of Di-(2-ethylhexyl) phthalate (DEHP). | |
V72288 | Monoethyl phthalate | 2306-33-4 | Monoethyl phthalate, a metabolite of diethyl phosphate, can serve as a urinary biomarker of phthalate exposure, indicating the risk of thyroid cancer and benign nodules. | |
V72131 | Monoethylglycinexylidide hydrochloride (MEGX hydrochloride; Norlidocaine hydrochloride) | 7729-94-4 | Monoethylglycinexylidide (MEGX) HCl is a metabolite of Lidocaine produced through oxidative metabolism by cytochrome P-450 enzymes in the liver. | |
V72237 | Mosapride N-Oxide | 1161443-73-7 | Mosapride N-Oxide is the main bioactive metabolite of mosapride. | |
V72106 | MTIC (temozolomide metabolite - MTIC) | 3413-72-7 | MTIC is the bioactive metabolite of Temozolomide (TMZ). | |
V72112 | Mycophenolic acid glucuronide | 31528-44-6 | Mycophenolic acid glucuronide is a metabolite of the immunosuppressant mycophenolic acid. | |
V72193 | N-(2-Hydroxyethyl)oxamic acid | 5270-73-5 | N-(2-hydroxyethyl)-oxamic acid is formed by the chemical or intestinal bacterial reduction of Metronidazole. | |
V72224 | N-Acetyl dapsone (MADDS; Monoacetyldapsone) | 565-20-8 | N-Acetyl dapsone (MADDS) is the major metabolite of dapsone. | |
V72191 | N-Acetyl mesalazine (N-Acetyl-5-aminosalicylic acid; N-Acetyl-ASA) | 51-59-2 | N-Acetyl mesalazine (N-Acetyl-5-aminosalicylic acid) is a metabolite of 5-Aminosalicylic Acid and has endoscopic activity. | |
V72284 | N-Carbethoxy-4-piperidone | 29976-53-2 | N-Carbethoxy-4-piperidone is a metabolite of Loratadine. | |
V67748 | N-Demethyl Mifepristone (RU 42633) | 104004-96-8 | N-Demethyl Mifepristone (RU 42633) is the bioactive metabolite of Mifepristone. | |
V72220 | N-Demethylerythromycin A (N-Demethylerythromycin A) | 992-62-1 | N-Demethylerythromycin A is a metabolite of Erythromycin A. | |
V72170 | N-Desalkyludenafil | 319491-68-4 | N-Desalkyludenafil is a metabolite of Udenafil. | |
V30776 | N-Desethyl Sunitinib (SU-11662) | 356068-97-8 | N-Desethyl Sunitinib(SU-11662) is a major metabolite of sunitinib which is a potent, ATP-competitive VEGFR, PDGFRβ and KIT inhibitor with Kis of 2, 9, 17, 8 and 4 nM for VEGFR -1, -2, -3, PDGFRβ and KIT, respectively. | |
V76713 | N-Desethyl Sunitinib hydrochloride (SU-12662 hydrochloride) | N-Desethyl Sunitinib (SU-12662) ( HCl) is a metabolite of Sunitinib. | ||
V72277 | N-Desmethyl imatinib mesylate (Norimatinib mesylate; Imatinib metabolite N-Desmethyl imatinib mesylate) | 404844-03-7 | N-Desmethyl imatinib mesylate (Norimatinib mesylate) is a metabolite of Imatinib. |